Home
About Us
Company Profile
Company Culture
Expert Team
Development Path
Honor
Main Business
Digital-one-stop Clinical Research Service
IT-based Medical R&D construction
Precision Medicine
Project Dynamics
Platform Display
CENTEN
LINKMEDS
PHAMARK
TONOINFO
DUXACT MEDICAL LABORATORY
News
Duzheng News
Recruitment
Talent Concept
Contact Us
Duzheng Family
Happy Duzheng
中文
On January 25, 2016, Duzheng Biotech was formally established
On October 24, 2016, the first medicine was established
On December 27, 2016, the establishment of the data
April 10, 2017 Established Tongnuo Information
July 26, 2017 Established Medical Laboratory
On October 17, 2018, Duzheng Biotech and Xianling Medicine were recognized as high-tech enterprises
On July 22, 2020, the founding meeting of Changsha Duzheng Biotechnology Co., Ltd. was successfully held
July 23, 2021 Changsha Duzheng Medical Laboratory was officially opened for business
Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!
On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved
On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved
On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved
September 13, 2021 Hunan Warner Pharmaceutical Co., Ltd. Entecavir Granules is the first nationwide approved
September 9th, 2021, the first national approval of Ritonavir Tablets by Guli Pharmaceutical (Zhejiang) Co., Ltd.
September 3, 2021 Hainan General Sanyo Pharmaceutical Co., Ltd. Vidagliptin tablets were successfully approved
On August 19, 2021, Chengdu Hengrui Pharmaceutical Co., Ltd. received approval for cetirizine hydrochloride tablets
On August 12, 2021, Zhejiang Hisun Pharmaceutical Co., Ltd.'s valsartan tablets were approved
July 22, 2021 Hunan Xiangzhong Pharmaceutical Co., Ltd. Sodium Valproate Tablets was approved as the third nationwide company
July 20, 2021 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Olopatadine Hydrochloride Tablets was approved for the third nationwide
May 11, 2021 Tiandi Hengyi Pharmaceutical Co., Ltd. successfully approved tofacitib citrate tablets
April 30, 2021 Jiangsu Tianyishi Pharmaceutical Co., Ltd. Moxifloxacin Hydrochloride Tablets was successfully approved
April 20, 2021 Hunan Dongting Pharmaceutical Co., Ltd. clozapine tablets were successfully approved
On March 12, 2021, Hainan Ludao Pharmaceutical Co., Ltd. was successfully approved for terazosin hydrochloride tablets
March 9, 2021 Zhejiang Hisun Pharmaceutical Co., Ltd. Apixaban tablets were successfully approved
On January 29, 2021, Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. successfully approved clozapine tablets
On January 29, 2021, the Amoxicillin Capsule (0.25g) of Haikou Pharmaceutical Factory Co., Ltd. was successfully approved
November 24, 2020 Hunan Jiudian Pharmaceutical Co., Ltd. Irbesartan tablets were successfully approved
On October 29, 2020, Zhuhai Tongyi Pharmaceutical Co., Ltd. obtained the third national approval for nateglinide tablets
On January 1, 2021, tongnuo information released the internal test version of intelligent clinical research management platform (ICP)
On October 10, 2020, China's first intelligent laboratory management platform (ILP) was released
In July 2020, yootrial auth joined hands with Guangdong Hong Kong Macao alliance and Pacific Medical Subject Information Management System (escreening) to realize mutual check of subject identity information among the three systems
On 1st, 2021, Tongnuo Information releases the internal beta version of the Intelligent Clinical Research Management Platform (ICP)
On 10, 2020, the first domestic intelligent laboratory management platform (ILP) was released
In July 2020, YooTrial Auth joined forces with the Guangdong-Hong Kong-Macao Alliance and Taimei Medical Subject Information Management System (eScreening) to achieve mutual check of subject identity information among the three-party systems
In May 2020, Yootrial Auth and Taimei Medical eScreening officially opened up
In November 2019, the Pharmaceutical Research Laboratory Information Management System (PharmLIMS) V1.0 was released
In September 2019, it successfully signed a contract with the Guangdong-Hong Kong-Macao Phase I clinical research joint platform to jointly build a subject database
In June 2019, the intelligent biological sample bank management system Pharm BioBank) V2.0 was released
April 2019 YooTrial Ethics V1.0 released
In December 2018, the clinical trial project management system (YooTrial CTMS) V1.0 was released
In November 2018, the electronic data acquisition system (YooTrial EDC) V1.0 was released
June 2018 Bioanalysis Laboratory Information Management System (PharmLIMS for DMPK) V1.0 was released
In April 2018, the recruitment and management platform for volunteers from the fundraiser was launched.
March 2018 Yootrial AUTH V1.0 was launched
In March 2018, the intelligent biological sample bank management system (Pharm BioBank) V1.0 was released
In April 2017, Tongnuo Information was established to independently develop pharmacy and clinical information systems
June 2021 Co-built clinical research center with Jiangxi Pingxiang Mining Group Co., Ltd. General Hospital
May 2021 Co-build clinical research center with Xiangya Boai Rehabilitation Hospital
May 2021 Co-build clinical research center with Hengyang Central Hospital
In April 2021, a clinical research center was established with the First People's Hospital of Hengyang City
March 2021 Deepen the strategic cooperation with the Clinical Research Center of Hunan Provincial People's Hospital
February 2021 and Zhuzhou Traditional Chinese Medicine Trauma Hospital to build a medical device clinical research center
January 2021 Co-built clinical research center with Qinzhou First People's Hospital
January 2021 Co-build a clinical research center with Changsha Maternal and Child Health Hospital
In December 2020, a clinical research center was established with Guangdong Occupational Disease Prevention and Treatment Institute
In November 2020, it reached a strategic cooperation with the Second People's Hospital of Yueyang City
In September 2020, it reached a strategic cooperation with Chongqing West District Hospital Co., Ltd.
July 2020 Signed a contract with Loudi Central Hospital to build a clinical research center
July 2020 reached a strategic cooperation with the First Affiliated Hospital of Guangdong Pharmaceutical University
July 2020 Signed a contract with Yuebei People's Hospital to build a clinical research center
May 2020 Co-established a clinical research center with CITIC Xiangya Reproductive and Genetic Hospital
March 2020 Co-built clinical research center with Huxiang Traditional Chinese Medicine Tumor Hospital (People's Hospital of Yuelu District, Changsha City)
March 2020 Co-established a clinical research center with Changsha Kexin Cancer Hospital
In November 2019, instructed Zhoukou Central Hospital to carry out the qualification accreditation of drug clinical trial institutions
September 2019 Duzheng Bio-Hunan Provincial People's Hospital Co-built Clinical Research Center was officially opened
In May 2019, it reached a strategic cooperation with Hunan Provincial People's Hospital
May 19, 2021 Improved new drugs & high-end preparation cutting-edge technology salon Jinan Station
October 10, 2020 The 3rd DDI/New Drug Innovation Forum Changsha Station
August 28, 2020 Qingdao Station, Seminar on the Development of Improved New Drugs and Complex Preparations
April 29, 2020 Online live broadcast-from PPI trap to Esomeprazole drug development case sharing
March 26, 2020 Online live broadcast-BE traps in PPI research
December 25, 2019 Highly Variant Drug BE Difficulties and Oral Proton Pump Inhibitor Case Analysis Seminar Shanghai Station
Online live broadcast on March 22, 2020-Pantoprazole sodium enteric-coated tablets research and development case sharing
December 11, 2019 Difficulties of highly variable drugs BE and oral proton pump inhibitor case analysis seminar Kunming Station
November 8, 2019 Highly mutated drug BE difficulties and oral proton pump inhibitor case analysis seminar Guangzhou station
September 6, 2019 Highly Variant Drug BE Difficulties and Oral Proton Pump Inhibitor Case Analysis Seminar Jinan Station
July 26, 2019 Difficulties of Highly Variant Drug BE and Case Analysis Seminar on Oral Proton Pump Inhibitors Chengdu Station
Seminar on Interpretation of BE Pre-test Results on July 12, 2019 Wuhan Station
June 28, 2019 BE Pre-test Results Interpretation Seminar Haikou Station
May 30, 2019 PPI Pharmacy Clinical Consistency Evaluation Symposium Beijing Station